Molvir 200Mg - Anti-COVID Generic Drug Molnupiravir

Molvir 200Mg - Anti-COVID Generic Drug Molnupiravir

Enquiry Now

Description

Additional Information

Molnupiravir is the world’s first oral pill to treat symptomatic COVID-19 which was approved by the UK’s Medicines and Healthcare products Regulatory Agency on 4 November 2021. Molnupiravir is originally developed by the US based pharma major Merck, Sharp & Dohme (MSD) and Ridgeback Biotherapeutics.

Why Choose Us

We have accumulated a strong and healthy market trust through the way we conduct our businesses. We are empowered by having an impeccable team responsible for administrative, commercial, technical and financial matters. We have accumulated a strong and healthy market trust through the way we conduct our businesses. We are empowered by having an impeccable team responsible for administrative, commercial, technical and financial matters. We have accumulated a strong and healthy market trust through the way we conduct our businesses. We are empowered by having an impeccable team responsible for administrative, commercial, technical and financial matters.

Our Vision

Our vision is to provide high quality, cost-effective healthcare that leverages technology to more adroit lines of treatment.

Our Mission

Premia Meds strives to provide pain-free, advanced healthcare solutions and a more progressive environment for disease control and treatment by pioneering new-age medical disposable products.